usdept depart health human servic usdept usbureau food drug administr usbureau cfrno 21 cfr part 442 444 448 455 cfrno rindock docket 93n0364 rindock antibiot drug updat technic chang correct agenc agenc food drug administr hh agenc action action final rule action summari summari food drug administr fda amend antibiot drug regul updat make noncontroversi technic chang make correct accept standard antibiot antibiot contain drug human use chang result accur usabl regul summari date date effect februari 22 1994 written comment notic particip request hear march 24 1994 data inform analys justifi hear april 25 1994 date address address submit written comment docket manag branch hfa305 food drug administr rm 123 12420 parklawn dr rockvil md 20857 address inform contact peter dionn center drug evalu research hfd520 food drug administr 5600 fisher lane rockvil md 20857 3014430335 supplem supplementari inform fda amend antibiot drug regul updat make noncontroversi technic chang make correct certain antibiot drug regul provid accept standard antibiot antibiot contain drug intend human use 442 216a 1 21 cfr 442 216a 1 separ limit pyridin content given l arginin formul sodium carbon formul separ limit need current limit allow l arginin formul contain 5 2 milligram mg pyridin per gram g ceftazidim activ sodium carbon formul may contain 4 4 mg pyridin per g ceftazidim activ 442 216a b 1 ii differ loss dri procedur given l arginin formul sodium carbon formul necessari procedur current monograph would remov water sodium carbon formul product water trap sodium hydrogen carbon procedur thu lead fals high potenc valu two formul contain differ amount ceftazidim pentahydr percent weight weight powder blend differ loss dri limit given formul loss dri limit 12 5 percent contain l arginin 13 5 percent contain sodium carbon asymmetri arginin peak also revis current limit 2 5 limit 4 0 limit realist valu obtain assay revis made descript certain ophthalm product 21 cfr part 444 peptid product 21 cfr part 448 fda discov monograph contain error would allow formul without preserv essenti inact ingredi fit monograph fda review product without ingredi know safe effect agenc therefor revis certain ophthalm monograph correct error 455 185a 1 21 cfr 455 185a 1 fda make revis allow vancomycin hydrochlorid oral solut contain suitabl stabil agent agenc review formul found safe effect environment impact agenc determin 21 cfr 25 24 c 6 action type individu cumul signific effect human environ therefor neither environment assess environment impact statement requir submit comment file object amend institut chang correct editori minor technic natur amend controversi effect provid notic accept standard fda find notic public procedur delay effect date unnecessari public interest final rule therefor becom effect februari 22 1994 howev interest person may march 24 1994 submit written comment docket manag branch address two copi comment submit except individu may submit one copi comment identifi docket number found bracket head document receiv comment may seen docket manag branch 9 4 p monday friday person advers affect final rule may file object request hear reason ground hear must shown person decid seek hear must file 1 march 24 1994 written notic particip request hear 2 april 25 1994 data inform analys person reli justifi hear specifi 21 cfr 314 300 request hear may rest upon mere alleg denial must set forth specif fact show genuin substanti issu fact requir hear conclus appear face data inform factual analys request hear genuin substanti issu fact preclud action taken order request hear made requir format requir analys commission food drug enter summari judgment person request hear make find conclus deni hear submiss must file three copi identifi docket number appear head document file docket manag branch procedur requir govern order notic particip request hear submiss data inform analys justifi hear comment grant denial hear contain 21 cfr 314 300 submiss order except data inform prohibit public disclosur 21 u c 331 j 18 u c 1905 may seen docket manag branch address 9 4 p monday friday list subject 21 cfr part 442 444 448 455 antibiot therefor feder food drug cosmet act author deleg commission food drug 21 cfr part 442 444 448 455 amend follow part 442_cepha antibiot drug 1 author citat 21 cfr part 442 continu read follow author sec 507 feder food drug cosmet act 21 u c 357 2 section 442 216a amend revis paragraph 1 b 1 ii b 4 read follow 442 216a ceftazidim pentahydr inject requir certif _ 1 standard ident strength qualiti puriti ceftazidim pentahydr inject dri mixtur ceftazidim pentahydr sodium carbon l arginin ceftazidim potenc satisfactori milligram ceftazidim pentahydr inject contain less 900 microgram 1 050 microgram cefazidim activ correct loss dri sodium carbon l arginin content appropri formul ceftazidim content satisfactori less 90 percent 120 percent number milligram ceftazidim repres contain steril nonpyrogen loss dri 12 5 percent contain l arginin 13 5 percent contain sodium carbon ph aqueou solut less 5 0 7 5 pyridin content contain sodium carbon 0 4 percent except issuanc certif batch sodium carbon formul pyridin content 0 12 percent pyridin content contain l arginin 0 3 percent except issuanc certif pyridin content l arginin formul 0 10 percent ceftazidim pentahydr conform standard prescrib 442 16a 1 b 1 ii calcul _ ceftazidim potenc microgram per milligram calcul microgram ceftazidim per milligram follow tabl 1microgram ceftazidim per milligram 1 1 u x p x 100 2 x c u x 100 tabl u area ceftazidim peak chromatogram sampl retent time equal observ standard area ceftazidim peak chromatogram ceftazidim work standard p ceftazidim activ ceftazidim work standard solut microgram per millilit c u milligram sampl per millilit sampl solut percent loss dri determin direct 436 200 h chapter formul contain sodium carbon determin direct 436 200 g chapter formul contain l arginin percent sodium carbon content sampl determin direct 436 357 chapter percent l arginin content sampl determin direct 455 204 chapter except use ceftazidim instead aztreonam work standard solut use water instead mobil phase prepar sampl solut dilut accur weigh portion content vial water 0 2 milligram per millilit estim resolut ceftazidim peak arginin peak less 6 0 asymmetri factor arginin peak 4 0 4 loss dri proceed direct 436 200 h chapter formul contain sodium carbon direct 436 200 g chapter formul contain l arginin part 444_oligosaccharid antibiot drug 3 author citat 21 cfr part 444 continu read follow author sec 507 feder food drug cosmet act 21 u c 357 4 section 444 320c amend revis second sentenc paragraph 1 read follow 444 320c gentamicin sulfat prednisolon acet ophthalm suspens 1 contain suitabl harmless chelat agent tonic agent buffer preserv 5 section 444 342a amend revis first sentenc undesign paragraph paragraph 1 v read follow 444 342a neomycin sulfat __________ ophthalm suspens neomycin sulfat _____________ ophthalm solut blank fill establish name activ ingredi present accord paragraph 1 section 1 v contain suitabl harmless buffer dispers preserv 6 section 444 342c amend revis first sentenc undesign paragraph paragraph 1 ii read follow 444 342c neomycin sulfat gramicidin _____________ ophthalm solut neomycin sulfat gramicidin _________ ophthalm suspens blank fill establish name activ ingredi present accord paragraph 1 section 1 ii contain suitabl harmless buffer dispers irrig preserv 7 section 444 342d amend revis first sentenc undesign paragraph paragraph 1 iv read follow 444 342d neomycin sulfat polymyxin b sulfat ___________ ophthalm suspens blank fill establish name activ ingredi present accord paragraph 1 section 1 iv contain suitabl harmless buffer dispers irrig preserv 8 section 444 342i amend revis second sentenc paragraph 1 ii read follow 444 342i neomycin sulfat polymyxin b sulfat ophthalm solut 1 ii contain suitabl harmless buffer dispers irrig preserv 9 section 444 342j amend revis second sentenc paragraph 1 read follow 444 342j neomycin sulfat polymyxin b sulfat dexamethason ophthalm suspens 1 contain suitabl harmless buffer dispers irrig preserv 10 section 444 380a amend revis second sentenc paragraph 1 read follow 444 380a tobramycin ophthalm solut 1 contain suitabl harmless buffer dispers preserv tonic agent 11 section 444 380c amend revis second sentenc paragraph 1 read follow 444 380c tobramycin dexamethason ophthalm suspens 1 contain suitabl harmless buffer dispers preserv tonic agent part 448_peptid antibiot drug 12 author citat 21 cfr part 448 continu read follow author sec 507 feder food drug cosmet act 21 u c 357 13 section 448 330 amend revis second sentenc paragraph 1 read follow 448 330 polymyxin b sulfat trimethoprim hemisulf ophthalm solut 1 contain suitabl harmless buffer preserv part 455_certain antibiot drug 14 author citat 21 cfr part 455 continu read follow author sec 507 feder food drug cosmet act 21 u c 357 15 section 455 185a amend paragraph 1 ad new sentenc first sentenc read follow 455 185a vancomycin hydrochlorid oral solut 1 may contain suitabl stabil agent date februari 9 1994 supplem signer stephani r gray signer signjob act director offic complianc center biolog evalu research signjob frfile fr doc 943856 file 21894 8 45 frfile bill bill code 416001f bill